Feedback / Questions
CTx1000 - Celosia Therapeutics
https://www.prnewswire.com/news-releases/celosia-therapeutics-announces-first-patient-dosed-in-phase-1b-clinical-trial-of-ctx1000-in-amyotrophic-lateral-sclerosis-302721815.html
Mar 23, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev